BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15724543)

  • 1. Monte Carlo evaluation of kerma in an HDR brachytherapy bunker.
    Pérez-Calatayud J; Granero D; Ballester F; Casal E; Crispin V; Puchades V; León A; Verdú G
    Phys Med Biol; 2004 Dec; 49(24):N389-96. PubMed ID: 15724543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Air-kerma evaluation at the maze entrance of HDR brachytherapy facilities.
    Pujades MC; Granero D; Vijande J; Ballester F; Perez-Calatayud J; Papagiannis P; Siebert FA
    J Radiol Prot; 2014 Dec; 34(4):741-53. PubMed ID: 25222942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
    Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of shielding door thicknesses for radiation therapy facilities using the ITS Monte Carlo program.
    Biggs PJ
    Health Phys; 1991 Oct; 61(4):465-72. PubMed ID: 1917483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo study of a 60Co calibration field of the Dosimetry Laboratory Seibersdorf.
    Hranitzky C; Stadtmann H
    Radiat Prot Dosimetry; 2007; 125(1-4):153-6. PubMed ID: 17337744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose reduction of scattered photons from concrete walls lined with lead: Implications for improvement in design of megavoltage radiation therapy facility mazes.
    Al-Affan IA; Hugtenburg RP; Bari DS; Al-Saleh WM; Piliero M; Evans S; Al-Hasan M; Al-Zughul B; Al-Kharouf S; Ghaith A
    Med Phys; 2015 Feb; 42(2):606-614. PubMed ID: 28102603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo evaluated parameters for internal dosimetry.
    Gualdrini G; Ferrari P
    Radiat Prot Dosimetry; 2007; 125(1-4):157-60. PubMed ID: 17553866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutron spectrometry around the VENUS reactor using Monte Carlo simulations and Bonner spheres measurements.
    Coeck M; Lacoste V; Muller H
    Radiat Prot Dosimetry; 2007; 125(1-4):170-4. PubMed ID: 17573369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo modeling for individual monitoring.
    Gualdrini G
    Radiat Prot Dosimetry; 2007; 125(1-4):139-44. PubMed ID: 17533157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo characterization of an ytterbium-169 high dose rate brachytherapy source with analysis of statistical uncertainty.
    Medich DC; Tries MA; Munro JJ
    Med Phys; 2006 Jan; 33(1):163-72. PubMed ID: 16485423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast GPU-based Monte Carlo simulations for LDR prostate brachytherapy.
    Bonenfant É; Magnoux V; Hissoiny S; Ozell B; Beaulieu L; Després P
    Phys Med Biol; 2015 Jul; 60(13):4973-86. PubMed ID: 26061145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of dose rates during the dismantling of JET.
    Loughlin MJ; Nathan RP
    Radiat Prot Dosimetry; 2005; 115(1-4):486-90. PubMed ID: 16381772
    [No Abstract]   [Full Text] [Related]  

  • 13. MCNPX vs. DORT for SNS shielding design studies.
    Popova II
    Radiat Prot Dosimetry; 2005; 115(1-4):559-63. PubMed ID: 16381785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainties in external dosimetry: analytical vs. Monte Carlo method.
    Behrens R
    Radiat Prot Dosimetry; 2010 Mar; 138(4):346-52. PubMed ID: 19942627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need to update NCRP 151 data for 10 MV linear accelerator bunker shielding based on new measurements and Monte Carlo simulations.
    Rijken J; Towns S; Healy B
    J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34624879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal dosimetry in terms of HP(3): Monte Carlo and experimental studies.
    Ferrari P; Gualdrini G; Bedogni R; Fantuzzi E; Monteventi F; Morelli B
    Radiat Prot Dosimetry; 2007; 125(1-4):145-8. PubMed ID: 17261537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional shielding calculations for the IFMIF neutron source using a coupled Monte Carlo/Deterministic computational scheme.
    Chen Y; Fischer U; Simakov SP; Wasastjerna F
    Radiat Prot Dosimetry; 2005; 115(1-4):573-9. PubMed ID: 16381788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical system utilising a Monte Carlo calculation method for accurate dose assessment in radiation accidents.
    Takahashi F; Endo A
    Radiat Prot Dosimetry; 2007; 126(1-4):595-9. PubMed ID: 17510203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.